Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia

Nuclear Medicine Communications

Volumn 33, Issue 10, 2012, Pages 1048-1052

  Farid, Karim ^a,b   Volpe Gillot, Lisette ^c   Petras, Slavomir ^d   Plou, Caroline ^c   Caillat Vigneron, Nadine ^a   Blacher, Jacques ^b,e  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c Saint Joseph Hospital   (France)

^d HÔTEL DIEU   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

25 hydroxyvitamin D; Alzheimer's disease; brain imaging; brain perfusion; brain single photon emission computed tomography; dementia; dementia of Lewy bodies; regional cerebral blood flow

Indexed keywords

25 HYDROXYVITAMIN D; CYSTEINE ETHYL ESTER TC 99M;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; COGNITION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GERIATRIC PATIENT; HUMAN; IMAGING SYSTEM; LEWY BODY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROLOGIC DISEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; CYSTEINE; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; REGIONAL BLOOD FLOW; VITAMIN D;

EID: 84865707331     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835674c4     Document Type: Article

References (21)

1. Lee DM, Tajar A, Ulubaev A, Pendleton N, O'Neill TW, O'Connor DB, et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009; 80:722-729.
2. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009; 16:1083-1089.
3. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 2007; 10: 12-19. (Pubitemid 44901128)
4. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
5. Evatt ML. Beyond vitamin status: is there a role for vitamin D in Parkinson disease? Arch Neurol 2008; 67:795-797.
6. Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992; 13: 239-250.
7. Bruandet A, Richard F, Bombois S, Maurage CA, Deramecourt V, Lebert F, et al. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry 2009; 80:133-139.
8. Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007; 48: 1289-1300. (Pubitemid 47242794)
9. Pogge E. Vitamin D and Alzheimer's disease: is there a link? Consult Pharm 2010; 25:440-450.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. (Pubitemid 14076461)
11. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113-1124. (Pubitemid 26374873)
12. Farid K, Caillat-Vigneron N, Sibon I. Is brain SPECT useful in degenerative dementia diagnosis? J Comput Assist Tomogr 2011; 35:1-3.
13. Friston KJ, Holmes AP, Poline JB, Grasby PJ,Williams SC, Frackowiak RS, et al. Analysis of fMRI time-series revisited. Neuroimage 1995; 2: 45-53.
14. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15:273-289. (Pubitemid 34852226)
15. Shima K, Matsunari I, Samuraki M, Chen WP, Yanase D, Noguchi-Shinohara M, et al. Posterior cingulate atrophy and metabolic decline in early stage Alzheimer's disease. Neurobiol Aging 2011. doi: S0197-4580(11)00287-9 [pii].
16. Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol 2010; 67:353-364.
17. Poduslo SE, Yin X. Chromosome 12 and late-onset Alzheimer's disease. Neurosci Lett 2001; 310:188-190. (Pubitemid 32822834)
18. Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, Emre M, et al. Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 2007; 212:275-282. (Pubitemid 47304994)
19. Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010; 67: 808-811.
20. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13:100-105. (Pubitemid 36733998)
21. Oudshoorn C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25: 539-543. (Pubitemid 351957417)